Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Anti-AMHR2 antibody increases the efficacy of conventional first-line chemotherapy

March 17, 2015

Immune Design studies combinatorial regimen CMB-305 for NY-ESO-1-expressing cancers

March 16, 2015

Oxis Biotech licenses rights to antibody-drug conjugates for cancer

March 16, 2015

BriaCell Therapeutics submits phase I/II protocol to the FDA

March 13, 2015

University of Toronto divulges new anti-Frizzled antibodies

March 12, 2015

FDA approves Unituxin for pediatric patients with high-risk neuroblastoma

March 11, 2015

Madison Vaccines confirms program expansions for prostate cancer vaccines

March 11, 2015

Heat Biologics receives FDA fast track designation for HS-410 in combination with BCG

March 10, 2015

arGEN-X exercises option to license antibody candidate for cancer immunotherapy

March 6, 2015

FDA approves Opdivo for metastatic squamous NSCLC

March 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...